Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

李偉平 (Wei-Ping Lee)

李偉平(Wei-Ping Lee)圖 Return Appointment First Appointment

[Profile]

  • Education
    • M.D., Department of Medicine; National Defense Medical Center, Taipei, Taiwan, R.O.C.,
    • Ph.D., Department of Tumor Biology; University of Texas-Houston M.D. Anderson Cancer Center,
  • Career and Experience
    Current Positions：
    • - Now, Adjunct attending staff, Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital,
    • - Now, Adjunct professor, Institute of Biochemistry and Molecular Biology, National Yang-Ming University,
    Experiences：
  • Medical Expertise
    1. Gastroenterology and Hepatology
    2. Gastrointestinal Endoscopy
    3. 1. Liver and gastrointestinal disease-diagnosis and management
    4. 2. Abdominal ultrasound and GI tract endoscopy
  • License
    ECFMG (Educational Committee for Foreign Medical Graduate, USA) Practice License of Physician, Taiwan, ROC Specialist License in Internal Medicine, Taiwan, ROC Specialist License in Gastroenterology, Taiwan, ROC
  • Language Expertise
    Chinese English

[Publications]

  1. Wang YK, Wang YW, Lu CL, Huang YH, Hou MC, Chang YL, Lee WP*, Lan KH. Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol. Scientific Report, 2022;12(1):9942.
  2. Lee WP*. Suppression of vacuolar-type ATPase and induction of endoplasmic reticulum stress by proton pump inhibitors. J Chin Med Assoc, 2022, in press.
  3. Wang YW, Lee WP, Huang YH, Hou MC, Lan KH. Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):984-995.
  4. Lee WP, Lan KL, Liao SX, Huang YH, Hou MC, Lan KH. Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus. J Chin Med Assoc. 2019;82:368-374.
  5. Lee WP, Lan KL, Liao SX, Huang YH, Hou MC, Lan KH. Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus. Am J Chin Med 2018;46:835-852.